Bio-Rad Laboratories, Inc.BIONYSE
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
17.85%
↑ 537% above average
Average (39q)
2.80%
Historical baseline
Range
High:53.44%
Low:-35.66%
CAGR
-1.2%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 17.85% |
| Q2 2025 | -17.69% |
| Q1 2025 | -7.69% |
| Q4 2024 | -12.50% |
| Q3 2024 | 53.44% |
| Q2 2024 | -7.30% |
| Q1 2024 | 2.83% |
| Q4 2023 | 42.90% |
| Q3 2023 | -33.07% |
| Q2 2023 | -13.22% |
| Q1 2023 | 13.22% |
| Q4 2022 | -5.36% |
| Q3 2022 | 4.35% |
| Q2 2022 | 12.60% |
| Q1 2022 | -14.80% |
| Q4 2021 | 8.36% |
| Q3 2021 | 1.72% |
| Q2 2021 | -14.23% |
| Q1 2021 | 12.39% |
| Q4 2020 | 10.44% |
| Q3 2020 | 14.55% |
| Q2 2020 | 5.44% |
| Q1 2020 | -13.61% |
| Q4 2019 | 19.03% |
| Q3 2019 | -4.35% |
| Q2 2019 | 5.35% |
| Q1 2019 | -10.36% |
| Q4 2018 | 7.78% |
| Q3 2018 | 3.78% |
| Q2 2018 | -4.00% |
| Q1 2018 | -35.66% |
| Q4 2017 | 25.17% |
| Q3 2017 | -2.00% |
| Q2 2017 | 26.54% |
| Q1 2017 | -14.00% |
| Q4 2016 | 15.26% |
| Q3 2016 | -4.31% |
| Q2 2016 | 7.38% |
| Q1 2016 | -13.06% |
| Q4 2015 | 28.96% |